14864-3 |
Oxygen |
PPres |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Oxygen [Partial pressure] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
mm Hg |
|
|
|
|
|
|
CHEM |
|
14864-3 |
|
|
|
|
Both |
|
|
|
0 |
pO2 BldCo |
|
|
|
Y |
|
Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; O2; O2 partial pressure; Partial pressure; PO2; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2 |
2.73 |
1.0k |
|
|
|
|
|
|
|
mm[Hg] |
|
|
|
0 |
14865-0 |
Parathyrin |
Imp |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
Parathyrin [Interpretation] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14865-0 |
|
|
|
|
Observation |
|
|
|
0 |
PTH SerPl-Imp |
|
|
|
|
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14866-8 |
Parathyrin.intact |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Parathyrin.intact [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
14866-8 |
|
|
|
|
Both |
|
|
|
0 |
PTH-Intact SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
14867-6 |
PARoxetine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
PARoxetine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14867-6 |
|
|
|
|
Both |
|
|
|
0 |
PARoxetine SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Paxil; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14868-4 |
Pathologist report |
Imp |
Plas/RBC |
Pt |
Nom |
|
|
ACTIVE |
Pathologist report of Plasma or RBC tests |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14868-4 |
|
|
|
|
Observation |
|
|
|
0 |
Path Report PlasRBC-Imp |
|
|
|
|
|
BLOOD BANK; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Path; Path Report; Pl; Plasma; PlasRBC; Plsm; Point in time; Random; Red blood cells; Red blood corpusles |
2.08 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14869-2 |
Pathologist review |
Imp |
Bld |
Pt |
Nom |
Pathologist comment |
|
ACTIVE |
Pathologist review of Blood tests |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14869-2 |
|
Pathologist comment |
|
|
Both |
|
|
|
0 |
Path Rev Bld -Imp |
|
|
|
|
|
Blood; BLOOD BANK; cmmt; cmnt; Com; Comm; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Path; Path Cmnt; Path Rev; Point in time; Random; UniversalLabOrders; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
1487-8 |
Gastrin^25M post 0.2 U/kg secretin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
1487-8 |
|
|
|
|
Observation |
|
|
|
0 |
Gastrin 25M p 0.2 U/kg SCT SerPl-mCnc |
|
|
|
Y |
|
25M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome |
2.34 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
14870-0 |
Pentacarboxylate |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Pentacarboxylate [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14870-0 |
|
|
|
|
Both |
|
|
|
0 |
Pentacarboxylate Plas-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14871-8 |
Pentacarboxylate |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Pentacarboxylate [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14871-8 |
|
|
|
|
Both |
|
|
|
0 |
Pentacarboxylate Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14872-6 |
Pentacarboxylate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Pentacarboxylate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14872-6 |
|
|
|
|
Both |
|
|
|
0 |
Pentacarboxylate Ur-sCnc |
|
|
|
Y |
|
Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14873-4 |
pH |
LsCnc |
BldCo |
Pt |
SemiQn |
|
|
ACTIVE |
pH of Cord blood |
|
MAJ |
DefinitionDescription |
|
|
pH |
|
|
|
|
|
|
CHEM |
|
14873-4 |
|
|
|
|
Both |
|
|
|
0 |
pH BldCo |
|
|
|
|
|
Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Log molar concentration; Point in time; Random; SmQn |
2.75 |
1.0k |
|
|
|
|
|
|
|
[pH] |
|
|
|
0 |
14874-2 |
PHENobarbital |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
PHENobarbital [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14874-2 |
|
|
|
|
Both |
|
|
|
0 |
Phenobarb SerPl-sCnc |
|
|
|
Y |
|
Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; Level; Luminal; Nirvonal; PHBR; Phenobarb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14875-9 |
Phenylalanine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenylalanine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L;mcmol/dL; mcmol/L |
|
|
|
|
|
|
CHEM |
|
14875-9 |
|
|
|
|
Both |
|
|
|
0 |
Phe SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Phe; Pl; Plasma; Plsm; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14876-7 |
Phenylpropanolamine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Phenylpropanolamine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14876-7 |
|
|
|
|
Both |
|
|
|
0 |
PPA Gast Ql |
|
|
|
|
|
Addiction; Dexatrim; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Norephedrine; Norephidrine; Ordinal; Point in time; PotentialForAbuse; PPA; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14877-5 |
Phenytoin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenytoin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14877-5 |
|
|
|
|
Both |
|
|
|
0 |
Phenytoin SerPl-sCnc |
|
|
|
Y |
|
DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Phenhydan; PHYT; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Substance concentration; Zentropil |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14878-3 |
Phosphate |
PrThr |
Calculus |
Pt |
Ord |
|
|
ACTIVE |
Phosphate [Presence] in Stone |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14878-3 |
|
|
|
|
Both |
|
|
|
0 |
Phosphate Stone Ql |
|
|
|
|
|
Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; i Phos; Inorganic phosphate; Kidney; Nephrology; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14879-1 |
Phosphate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phosphate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14879-1 |
|
|
|
|
Both |
|
|
|
0 |
Phosphate SerPl-sCnc |
|
|
|
Y |
|
Chemistry; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
1488-6 |
Gastrin^30M post 0.2 U/kg secretin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
1488-6 |
|
|
|
|
Observation |
|
|
|
0 |
Gastrin 30M p 0.2 U/kg SCT SerPl-mCnc |
|
|
|
Y |
|
30M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome |
2.34 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
14880-9 |
Phosphate |
SCnc |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Phosphate [Molecules/volume] in Urine |
|
DEL |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14880-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Phosphate Ur-sCnc |
|
|
|
Y |
|
Chemistry; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.36 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
14881-7 |
Phosphate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Phosphate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
14881-7 |
|
|
|
|
Both |
|
|
|
0 |
Phosphate 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; i Phos; Inorganic phosphate; Kidney; Nephrology; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
14882-5 |
Porphobilinogen |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Porphobilinogen [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
14882-5 |
|
|
|
|
Both |
|
|
|
0 |
PBG 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; PBG; Porph; Porphobili; Porphoblngn; Porpoblngn; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
14883-3 |
Porphyrins |
Imp |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
Porphyrins [Interpretation] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14883-3 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrins SerPl-Imp |
|
|
|
|
|
Chemistry; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; Porph; Porphyrin; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14884-1 |
Porphyrins |
Imp |
Stool |
Pt |
Nom |
|
|
ACTIVE |
Porphyrins [Interpretation] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14884-1 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrins Stl-Imp |
|
|
|
|
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Porph; Porphyrin; Random; Stl; Stool = Fecal |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14885-8 |
Pregnanediol |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Pregnanediol [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
14885-8 |
|
|
|
|
Both |
|
|
|
0 |
Pregnanediol 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
14886-6 |
Pregnanetriol |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Pregnanetriol [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14886-6 |
|
|
|
|
Both |
|
|
|
0 |
Pregntrl 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Pregnanetr; Pregntrl; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.58 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |